Patents Assigned to Relevare Aust. Pyt. Ltd.
  • Publication number: 20110224147
    Abstract: A method for inducing an analgesic response to inflammatory or neuropathic pain by administration of 1-(2-(4-chlorophenyl)-2-hydroxy)ethyl-4-(3,5-bis(1,1 dimethyl)-4-hydroxyphenyl)methyl piperazine, also called CNSB002 or AM-36, either alone or with an opioid and/or a neurokinin (NK) antagonist.
    Type: Application
    Filed: July 31, 2009
    Publication date: September 15, 2011
    Applicant: Relevare Aust. Pyt. Ltd.
    Inventor: Colin Stanley Goodchild